Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to...
New Haven United States Pfizer Inc Biohaven Pharmaceutical Holding Co Biohaven Pharmaceutical Holding Tom Murphy
Source: ctinsider.com